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Abstract 
Background: To determine the frequency of 
various gynaecological malignancies and to describe 
the age distribution, stage and clinical presentation 
of various gynaecological malignancies. 
Methods: In this descriptive study all patients 
with Gynecological malignancies were included in 
the study irrespective of the age and stage of the 
diseases.Patients with breast cancer associated with 
Pelvic Cancer were excluded from the study.Clinical 
data was collected from the patients by taking 
history and performing relevant examination and 
filling up the attached questionnaire/ performa.  
Results: There were 15 cases with ovarian  cancer, 
nine of cervical cancer, three cases of endometrial 
cancer, two cases of vulvar cancer and one case of  
chorio carcinoma. Age of the patients with cervical 
cancer ranged from 45-67 years. Endometrial cancer 
presented at mean age of 56 years. In ovarian cancer 
age of patients ranged from 24-63 years. The mean 
age of patients with vulvar cancer was 72.5 years. 
The age of the patient with choriocarcinoma was 32 
years. Weight loss, vaginal bleeding and discharge, 
menstrual irregularities, post menopausal bleeding 
were common clinical manifestations .  Most of the 
patients, in all types, presented in late stages. 
Conclusion: Patients with gynecological 
malignancies have good prognosis, if cancer is 
detected at an early stage. Therefore efforts should 
be made to encourage women to seek medical advice 
at first abnormal symptom. 
Key Words: Pelvic malignancies, Gynecological 
 Malignancies, Ovarian carcinoma, endometrial 
carcinoma, cervical cancer. 
 
Introduction 
     Cancer of the female genital tract constitutes a 
significant number of cancers seen in women in 
Pakistan. 1 In industrialized countries, the incidence of 
invasive cervical CA is on decline. With the 
availability of cervical cytology, screening and 
colposcopy a great number of patients with cervical 
cancer are now diagnosed when the disease is 
confined to the epithelium or in early stages of 
invasion. In Pakistan, cervical cancer is the commonest 
malignancy of the genital tract in females with relative 
frequency of 8.8%. The majority of the cases are seen at 
an advanced stage and therefore associated with a 
high morbidity and mortality. Carcinoma of the 
endometrium is the commonest  gynaecological 
malignancy among  western women, but its incidence 
is low in women from Asia.  Endometrial cancer is 
relatively rare in the premenopausal women. Factors 
associated with increased risk of developing 
endometrial cancer include obesity, diabetes mellitus, 
high fat , low complex carbohydrate diet, sedentary 
life style, early menarche, late menopause, prolonged 
/ irregular bleeding, nulliparity, polycystic ovarian 
syndrome, functioning ovarian tumour, unopposed 
estrogen therapy and tamoxifen use etc. The vast 
majority of women present with abnormal bleeding. 
The remaining have a discharge or pain. 2 
    Carcinoma of the ovary is common in developed 
areas and is the commonest cause of gynaecological 
cancer deaths. It affects between 1-2% of women in the 
developed worlds. Most ovarian tumours are of 
epithelial origin. The remainder are sex cord stromal 
tumour and  germ cell tumours. Epithelial tumours 
usually occur in old age while 90% of Germ cell 
tumours occur in young women less than 30 years old. 
Factors associated with the increased risk of 
developing ovarian cancer include reduced family 
size, later age at first conception, family history, and 
use of fertility drugs and patients of higher socio-
economical status2. Abdominal pain or discomfort are 
the most common presenting complaints and 
distention or feeling a lump the next most frequent.  
   Invasive Vulvar carcinoma is an uncommon but 
potentially curable disease even in elderly. 3 The mean 
age is between 60-74 years. Some 5% are melanomas 
and remaining are made up of carcinoma of 
Bartholin’s gland.Most patients complain of irritation 
or pruritis and some with a Vulvar mass or ulcer. 
Bleeding and discharge are less common 
presentations. Invasive vaginal cancer accounts for 1-
2% of all gynaecological malignancies. It arises as 
primary cancer or is the result of extension from the 
cervix or vulva. The most common presenting 
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symptom is vaginal bleeding. Vaginal discharge and 
pelvic pain are less common. Choriocarcinoma is 
highly malignant in behaviour, appearing as a soft, 
purple, largely hemorrhagic mass.4 About 50% are 
preceded by hydatidiform mole. The presenting 
features are vaginal bleeding, abdominal pain and 
pelvic mass. Patients may present with chest 
symptoms due to lung metastasis like dyspnoea and 
hemoptysis.5 
 
Patients and Methods 
     This descriptive study was conducted in 
Department of General Surgery unit B Post Graduate 
Medical Institute, Lady Reading Hospital, Peshawar 
and Department of Obstetrics and Gynecology unit  C 
Khyber Teaching Hospital Peshawar,from  October 
2013 to September 2014. All patients with 
Gynecological malignancies were included in the 
study irrespective of the age and stage of the 
disease.Patients with breast cancer associated with 
Pelvic Cancer were excluded from the study.Clinical 
data was collected from the patients by taking history 
and performing relevant examination and filling up 
the attached questionnaire/ proforma.  
 
Results 
    During one year of study, there were 30 cases of 
gynecological malignancies. Out of 30 patients 
diagnosed as cancer, Ovarian cancer(50%) was the 
commonest (Table 1).In 9 patients diagnosed as  
cervical cancer, majority (44.4 %) were in the 7th 
decade of life, followed by 33.3 % in 6th decade. The 
most common presenting complaint was weight 
loss(77.8 %) and  vaginal discharge (66.7%). Maximum 
number of patients (66.7%)  presented in stage II(Table 
2).  
     In three patients diagnosed as Endometrial cancer , 
majority (66.7 %)  were in 6th decade of life. The most 
common presenting complaint was vaginal discharge, 
followed by post menopausal bleeding and weight 
loss. Most patients presented in stage I, while one 
patient presented in stage III (Table 3).In the 15 
patients diagnosed as  Ovarian carcinoma, 4 (26.7 %) 
were in the 4th decade of life. Two patients were below 
30 years, while 3 patients each were in 5th, 6th and 7th 
decade of life. The most common presenting complaint 
was abdominal pain followed by abdominal 
distension, weight loss, menstrual problems, 
abdominal mass and urinary symptom etc. Maximum 
number of patients (40 %) presented in stage IV (Table 
4).During the study period, there were 2 cases of 
vulvar cancer. Both were in 8th decade of life, the most 
common presenting symptom was pruritis vulvae 
followed by vulvar ulcer, mass and urinary 
symptoms(Table 5). Both patients presented in stage 
III.Only one patient of Choriocarcinoma was 
diagnosed at the age of 32 years with complaints of 
vaginal bleeding. 
 
Table 1: Pattern of pelvic malignancies 
Type No(%) 
Ovarian carcinoma 15(50) 
Cervical carcinoma 9(30) 
Endomterial carcinoma 3(10) 
Vulvar carcinoma 2(6.6) 
Choriocarcinoma 1(3.3) 
 
Table 2:Carcinoma cervix-Clinical presentation 
and Stage of the disease 
Variable  No Percentage 
Presenting Complaints 
Weight loss 7 77.8 
Vaginal discharge  6 66.7 
Pain hypogastrium 5 55.6 
Postmenopausal bleeding 4 44.4 
Postcoital bleeding  3 33.3 
Urinary frequency 3 33.3 
Urinary retention  2 22.2 
Dysuria  2 22.2 
Nausea / Vomiting  2 22.2 
Hematuria  1 11.1 
Stage of disease 
Stage IIb 6 66.7 
Stage IIIa 1 11.1 
Stage IIIb 2 22.2 
 
Table 3:Carcinoma Endometrium-Clinical 
presentation and Stage of the disease 
     No Percentage  
Presenting Complaints 
Vaginal discharge 2 66.7 
Postmenopausal bleeding 1 33.3 
Per vaginal bleeding 1 33.3 
Weight loss 1 33.3 
Stage of Disease 
Stage Ia 1 33.3 
Stage Ib 1 33.3 
Stage IIIa 1 33.3 
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Table 4: Carcinoma Ovary-Clinical presentation 
and Stage of the disease 
Variable  No Percentage  
Presenting Complaints 
Abdominal pain 13 86.7 
Abdominal distention 10 66.7 
Weight loss 8 53.3 
Nausea / Vomiting 4 26.7 
Postmenopausal bleeding 3 20 
Hematuria  2 13.3 
Abdominal mass 2 13.3 
Anorexia  2 13.3 
Dysuria  2 13.3 
Constipation 1 6.7 
Body aches 1 6.7 
Oedema leg 1 6.7 
Pain epigastrium 1 6.7 
Menstrual irregularities 1 6.7 
Axial and neck swellings 1 6.7 
Stage of Disease 
Stage Ia 1 6.7 
Stage Ic 4 26.7 
Stage IIIc 4 26.7 
Stage IV 6 40 
 
Table 5: Carcinoma Vulva-Clinical 
 presentation and stage 
Presenting  
Complaints 
No Percentage 
Pruritis vulvae 2 100 
Burning micturation 1 50 
Mass 1 50 
Ulcer 1 50 
Urinary incontinence 1 50 
Stage of Disease   
Stage III 2 100 
 
Discussion 
     Cervical cancer is the second most common female 
cancer worldwide. In industrialized countries, the 
incidence of invasive cervical Ca is on decline. With 
the availability of cervical cytology, screening and 
colposcopy a great number of patients with cervical 
cancer are now diagnosed when the disease is 
confined to the epithelium or in early stages of 
invasion. In our study 77.7 % of the patients of Ca 
Cervix were above 50 years of age. The age range was 
from 45-67 years, this is similar to other studies.6 The 
most common symptoms encountered in the study 
were vaginal discharge, post menopausal bleeding and 
post coital bleeding .The study conducted at Lady 
Willington Hospital Lahore also showed that  
carcinoma Cervix was the commonest cause of  per 
vaginal bleeding 7 . Most of the patients presented in 
stage II and III. The results of the study conducted at 
Jinnah  Hospital Lahore showed that  most common 
stage of presentation of  Cervical cancer was III and IV 
due to absence of cervical screening programme, lack 
of public awareness and delay on part of patients to 
get timely treatment.8 PAP smear, an inexpensive test 
can detect the abnormal changes in cervical cells at an 
earlier stage. In advanced world the rate of carcinoma 
cervix is high due to their immoral sexual norms. In 
that set up repeated PAP smears are advised.  
     Endometrial carcinoma is the disease of peri and 
post menopausal women. The incidence is low in 
women younger than 40 years but rises rapidly and 
plateaus after the menopause as 44 per 100,000 
women. Only 2-14% of patients are 40 years of age or 
younger . In our study all patients were above 50 years 
of age. Median age was 56 years, which is comparable 
to other studies. The most common presenting 
complaint observed in our study was vaginal 
discharge (66.7 %), post menopausal bleeding (33.3 %), 
irregular per vaginal bleeding (33.3 %). This is similar 
to other studies. 9 
      Ovarian carcinoma is the leading cause of death, 
among Gynaecologic malignancies. The majority of 
patients are diagnosed in advanced stage. In our study 
60 % of patients were above 40 years of age. The age 
range was from 24-63 years. The most common 
symptoms encountered in the study were abdominal 
pain, abdominal distension, other gastro-intestinal 
symptoms ,urinary and menstrual irregularities. Most 
of our patients were in stage III and IV on 
presentation. This is similar to the findings of other 
studies..10 Invasive Vulvar carcinoma is an uncommon 
and unpleasant but potentially curable disease even in 
elderly, unfit women if diagnosed early and managed 
correctly from the outset. If mismanaged, the patient 
with Vulvar cancer is condemned to a miserable, 
degrading death. Vulvar cancer is rare; representing 5-
8 % of genital cancers, the mean age is between 60-74 
years 3 . In our study, 6.66 % patients presented with 
Ca vulva at mean age of 72.5 years, which is 
comparable to other studies. Both patients presented 
in stage III. No case of vaginal cancer was diagnosed 
as it is a rare tumour and accounts for 1-2 % of all 
gyaecological malignancies. In choriocarcinoma,  
simple measurement of the hCG level in such 
individuals is a very strong indicator of 
choriocarcinoma and could help to hasten referrals for 
life-saving chemotherapy 
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Conclusion 
1. Cervical cancer is quite prevalent in Pakistan 
and majority of patients present in advanced 
stage 
2. PAP smear, an inexpensive test , has proved to 
be effective in making an early diagnosis of 
cervical cancer. 
3. Efforts must be made to encourage women to 
seek medical advice at the first abnormal 
symptom. This may allow an earlier detection of 
malignancy. 
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